Related Experiment Videos

SOCS: suppressors of cytokine signalling

R Starr1, D J Hilton

  • 1Cooperative Research Centre for Cellular Growth Factors, Parkville, Vic., Australia. starr@wehi.edu.au

Insights

Suppressors of cytokine signalling (SOCS) proteins are newly identified negative regulators of cytokine signal transduction. These proteins, induced by cytokines, downregulate JAK/STAT pathways, controlling cellular responses and potentially impacting diseases like cancer.

Area of Science:

  • Cell Biology
  • Immunology
  • Molecular Biology

Background:

  • Cytokine signaling regulates cell behavior via cell surface receptors and cytoplasmic pathways.
  • Few molecules are known to inhibit cytokine signaling, necessitating identification of negative regulators.
  • Suppressors of Cytokine Signalling (SOCS) proteins represent a novel class of negative regulators.

Purpose of the Study:

  • To investigate the role of SOCS proteins in regulating cytokine signal transduction.
  • To understand the molecular structure and function of SOCS proteins.
  • To explore the potential involvement of SOCS in broader cellular responses and disease.

Main Methods:

  • Analysis of SOCS protein structure, including SH2 domains and SOCS boxes.
  • Investigating cytokine-induced expression of SOCS proteins.
  • Examining the downregulation of JAK/STAT pathways by SOCS.
  • Utilizing knockout mouse models to clarify physiological roles (proposed).

Main Results:

  • SOCS proteins possess distinct structural domains (amino-terminal, SH2, SOCS box).
  • SOCS protein expression is induced by cytokine stimulation.
  • SOCS proteins effectively downregulate JAK/STAT signaling pathways.
  • Preliminary evidence suggests SOCS may regulate additional signaling pathways.

Conclusions:

  • SOCS proteins are critical negative regulators of cytokine signaling, primarily via JAK/STAT pathway inhibition.
  • Further research, including knockout mouse studies, is needed to fully elucidate the physiological roles of SOCS.
  • Dysregulation of SOCS activity may contribute to diseases like diabetes and cancer, suggesting therapeutic potential.

Related Concept Videos